⌘K

Login Start Free

Home/Filings/4/A/0001127602-17-012942

4/A//SEC Filing

Bioverativ Inc. 4/A

Accession 0001127602-17-012942

CIK 0001681689operating

View on SEC.gov Company Profile

Filed

Mar 26, 8:00 PM ET

Accepted

Mar 27, 4:22 PM ET

Size

9.9 KB

Accession

0001127602-17-012942

Insider Transaction Report

Form 4/AAmended

Period: 2017-02-14

Bioverativ Inc.BIVV

EVP, HR & Corp Commun. Officer

Transactions

Award
Non-Qualified Stock Option
2017-02-14+14,899→ 14,899 total
Exercise: $44.51Exp: 2027-02-14→ Common Stock (14,899 underlying)
Award
Non-Qualified Stock Option
2017-02-14+59,595→ 59,595 total
Exercise: $44.51Exp: 2027-02-14→ Common Stock (59,595 underlying)
Award
Non-Qualified Stock Option
2017-02-14+29,797→ 29,797 total
Exercise: $44.51Exp: 2027-02-14→ Common Stock (29,797 underlying)

Footnotes (3)

[F1]The number of derivative securities acquired, the amount or number of shares and the number of derivative securities beneficially owned following the reported transaction have been amended from the original filing.
[F2]This option vests in three equal annual installments beginning on February 14, 2018.
[F3]This option vests in full on the third anniversary of the date of grant.

Documents

1 file

4
form4a.xml
PRIMARY DOCUMENT

Issuer

Bioverativ Inc.

CIK 0001681689

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0001681689

Filing Metadata

Form type: 4/A
Filed: Mar 26, 8:00 PM ET
Accepted: Mar 27, 4:22 PM ET
Size: 9.9 KB

View on SEC.gov